Twinlab Sales Affected By Effort To Improve Sell-Through, Infrastructure
This article was originally published in The Tan Sheet
Executive Summary
Twinlab sales for the second quarter fell 11% to $74.2 mil. from $83.3 mil. for the comparable period last year. Net income was $1.8 mil., a 73% drop from $6 mil. for the same period of 1998, the company announced July 27.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning